☆ 4.4 Review

Underlying Features of Prostate Cancer-Statistics, Risk Factors, and Emerging Methods for Its Diagnosis

CURRENT ONCOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Urology & Nephrology

Impact of the COVID-19 pandemic on the diagnosis and treatment of men with prostate cancer

Julie Nossiter et al.

Summary: This study investigated the impact of the COVID-19 pandemic on diagnostic and treatment activity for prostate cancer (PCa) in the English National Health Service. The results showed a 30.8% reduction in the number of newly diagnosed PCa cases in 2020 after the start of the first lockdown, with the diagnosed men typically being at a more advanced stage and slightly older. Treatment patterns shifted towards safer options, such as increased use of transperineal biopsy, hypofractionated radiation, and enzalutamide.

BJU INTERNATIONAL (2022)

Add to Collection

Article Oncology

The prostate cancer landscape in Europe: Current challenges, future opportunities

Maximilian Marhold et al.

Summary: This short review provides an insight into the treatment landscape of prostate cancer in Europe, with a focus on improvements in care.

CANCER LETTERS (2022)

Add to Collection

Review Oncology

Emerging role of exosomes as biomarkers in cancer treatment and diagnosis

Niloofar Asadi Hanjani et al.

Summary: Cancer is a leading cause of death worldwide, with rapidly growing incidence and mortality rates. The current methods used for cancer diagnosis and treatment are invasive and cost-effective. Recent research has revealed the effective roles of exosomes as promising biomarkers for diagnosis, prognosis, and prediction. Exosomes, which are membrane-bound extracellular vesicles containing genetic material and proteins, can detect various types of cancers at early stages with high sensitivity and specificity, and can also efficiently deliver therapeutic drugs.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

Add to Collection

Review Oncology

Obesity and prostate cancer: A narrative review

Rebekah L. Wilson et al.

Summary: Overweight and obese men with prostate cancer have a higher risk of disease recurrence, adverse effects from treatment, obesity-related comorbidities, disease progression, and mortality rates. The physiological mechanisms linking obesity and poor prostate cancer outcomes are unknown, but are commonly associated with inflammation and metabolic irregularities. Limited research suggests that fat loss strategies through exercise and nutrition programs may slow down prostate cancer progression and improve patient outcomes.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2022)

Add to Collection

Review Oncology

RNA-based biomarkers for the diagnosis, prognosis, and therapeutic response monitoring of prostate cancer

Juhyeon Bae et al.

Summary: Prostate cancer, the most common malignant neoplasm of the urinary tract, requires improved biomarkers for early clinical detection. RNAs have shown potential as non-invasive biomarkers with high sensitivity and specificity. Analysis of RNA levels can help determine individualized therapy for different stages of prostate cancer.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2022)

Add to Collection

Article Medicine, General & Internal

Machine Learning and Clinical-Radiological Characteristics for the Classification of Prostate Cancer in PI-RADS 3 Lesions

Michela Gravina et al.

Summary: This study evaluates the application of machine learning methods in detecting prostate cancer in patients with PI-RADS score 3 lesions. The results show that machine learning algorithms can generate malignancy probabilities based on clinical and radiological information, providing assistance to physicians in diagnostic decisions.

DIAGNOSTICS (2022)

Add to Collection

Review Oncology

Volatilomics: An Emerging and Promising Avenue for the Detection of Potential Prostate Cancer Biomarkers

Cristina Berenguer et al.

Summary: The lack of specific and sensitive biomarkers for early detection of prostate cancer is a major challenge. Volatilomics, a non-invasive and cost-effective approach, shows promise in identifying biomarkers for cancer screening and treatment evaluation. By combining with other methodologies, volatilomics can provide valuable insights for personalized treatments.

CANCERS (2022)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Artificial intelligence for prostate MRI: open datasets, available applications, and grand challenges

Mohammed R. S. Sunoqrot et al.

Summary: Artificial intelligence for prostate MRI has the potential to play a clinical role, reducing workflow and improving efficiency. However, further research and validation on large-scale multi-institutional datasets are needed to assess its general applicability.

EUROPEAN RADIOLOGY EXPERIMENTAL (2022)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Tasks for artificial intelligence in prostate MRI

Mason J. Belue et al.

Summary: The utilization of artificial intelligence (AI) in the prostate cancer diagnostic pathway has great potential to improve accuracy in various steps. More prospective multicenter studies are needed to uncover the full impact and utility of AI on radiologist performance and cancer management.

EUROPEAN RADIOLOGY EXPERIMENTAL (2022)

Add to Collection

Review Nutrition & Dietetics

Why has Japan become the world's most long-lived country: insights from a food and nutrition perspective

Shoichiro Tsugane

Summary: Japan has the longest average life expectancy among G7 countries, mainly due to low mortality rates from ischemic heart disease and cancer. This is thought to be attributed to factors such as low prevalence of obesity, high intake of fish and soybeans, and low intake of red meat.

EUROPEAN JOURNAL OF CLINICAL NUTRITION (2021)

Add to Collection

Review Chemistry, Applied

Tomato and lycopene and multiple health outcomes: Umbrella review

Ni Li et al.

Summary: This study aimed to clarify the associations between tomato and lycopene and multiple health outcomes. The intake of tomato and lycopene was shown to have protective effects against various diseases.

FOOD CHEMISTRY (2021)

Add to Collection

Article Urology & Nephrology

Novel PET imaging methods for prostate cancer

Esther Mena et al.

Summary: Among the available PET agents for prostate cancer, PSMA PET has emerged as the leader, showing greater sensitivity and specificity compared to other agents. PSMA PET is likely to have a significant impact on the diagnosis, staging, and management of prostate cancer patients.

WORLD JOURNAL OF UROLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Prostate Cancer Theranostics PSMA Targeted Therapy

Robert Seifert et al.

PET CLINICS (2021)

Add to Collection

Article Hematology

Application of extracellular vesicles in the diagnosis and treatment of prostate cancer: Implications for clinical practice

Oliver Oey et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

Prostate cancer: Molecular imaging and MRI

Farshad Moradi et al.

Summary: Molecular imaging is rapidly evolving in the initial evaluation of prostate cancer, biochemical recurrence, and metastatic disease, offering superior diagnostic performance compared to anatomic imaging, yet facing challenges due to variable tumor biology and metabolic alterations.

EUROPEAN JOURNAL OF RADIOLOGY (2021)

Add to Collection

Review Endocrinology & Metabolism

Knowledge of prostate cancer among African American men: A systematic review

Steven S. Coughlin et al.

Summary: Recent studies show that many African American men lack knowledge about prostate cancer and early detection. This lack of knowledge is particularly prevalent among older, less-educated, lower-income, unmarried men, as well as those without regular healthcare or insurance. Culturally appropriate educational efforts are needed to inform African American men about these issues.

PROSTATE (2021)

Add to Collection

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Add to Collection

Review Nutrition & Dietetics

Dietary Factors and Prostate Cancer Development, Progression, and Reduction

Michal Oczkowski et al.

Summary: Nutrients and food consumption play a significant role in the etiology and prevention of prostate cancer. Certain nutrients and food products can disrupt prostate hormonal regulation, induce oxidative stress and inflammation, and alter growth factor signaling and lipid metabolism, contributing to prostate carcinogenesis. On the other hand, a high consumption of vegetables, fruits, fish, and whole grain products has protective and/or therapeutic effects against prostate cancer.

NUTRIENTS (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Mechanistic Insights into the Link between Obesity and Prostate Cancer

Bamidele A. Adesunloye

Summary: Obesity is associated with the risk of prostate cancer through mechanisms such as chronic low-level inflammation and biological changes that promote malignant transformation. Understanding these mechanisms may be valuable in developing effective prostate cancer prevention strategies and treatments.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Biomarkers in Prostate Cancer Diagnosis: From Current Knowledge to the Role of Metabolomics and Exosomes

Stefano Salciccia et al.

Summary: Early detection of prostate cancer relies on PSA levels, but it lacks the ability to distinguish between benign and clinically significant forms of the disease. New urinary and serum biomarkers have been developed, but specific guidelines on their use are currently lacking.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Hereditary Prostate Cancer: Genes Related, Target Therapy and Prevention

Maria Teresa Vietri et al.

Summary: Genetic factors play a crucial role in the development of prostate cancer, with mutations in mismatch repair and homologous recombination genes being associated with susceptibility. Patients with these mutations may benefit from specific drug therapies. Detecting genetic alterations can help predict treatment responses and optimize treatment strategies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Letter Biochemistry & Molecular Biology

Circulating exosomal mRNA profiling identifies novel signatures for the detection of prostate cancer

Jin Ji et al.

Summary: The study developed an optimized detection strategy for emRNAs and identified novel emRNA signatures for the detection of prostate cancer.

MOLECULAR CANCER (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics

Ana Rita Lima et al.

Summary: Prostate cancer is the second most diagnosed cancer in men worldwide. Metabolomics studies have found consistent alterations in specific metabolites in prostate cancer tissue and urine, suggesting the potential for novel biomarker discovery. Valencia, taurine, leucine, and citrate were found to be commonly altered in both urine and tissue studies, indicating a promising strategy for prostate cancer diagnosis.

METABOLITES (2021)

Add to Collection

Review Oncology

Metabolic reprogramming in prostate cancer

Fahim Ahmad et al.

Summary: While low-risk localized prostate cancer has a good prognosis with effective treatments, metastatic prostate cancer remains incurable and treatment resistance is a major issue. Resistance is primarily driven by tumor heterogeneity, altered genetic signatures, and metabolic reprogramming enabling tumors to adapt to drugs. Understanding prostate cancer metabolism may offer insights into therapy-induced adaptive responses and more durable therapeutic outcomes.

BRITISH JOURNAL OF CANCER (2021)

Add to Collection

Review Endocrinology & Metabolism

Emerging Role of Extracellular Vesicles in Prostate Cancer

Megan Ludwig et al.

Summary: Contents within extracellular vesicles (EVs) have emerged as promising biomarkers that can provide valuable information about disease state and are acquired through noninvasive liquid biopsies. In prostate cancer, EVs play a crucial role in facilitating effective communication between cancer cells and the microenvironment, impacting important cellular processes such as metastasis, immune regulation, and drug resistance.

ENDOCRINOLOGY (2021)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

PSMA radioligand therapy for solid tumors other than prostate cancer: background, opportunities, challenges, and first clinical reports

M. J. M. Uijen et al.

Summary: PSMA-RLT shows promising results in prostate cancer and may have potential applications in other solid tumors. PSMA is expressed in varying degrees in other malignancies, suggesting a broader clinical implementation of PSMA-RLT beyond prostate cancer.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)

Add to Collection

Review Urology & Nephrology

Prostate-specific Antigen Testing as Part of a Risk-Adapted Early Detection Strategy for Prostate Cancer: European Association of Urology Position and Recommendations for 2021

Hendrik Van Poppel et al.

Summary: The European Association of Urology in 2021 presented a risk-adapted strategy for early prostate cancer detection using PSA testing, risk calculators, and multiparametric magnetic resonance imaging. This approach aims to reduce overdiagnosis/overtreatment and improve quality of life by diagnosing significant cancer early.

EUROPEAN UROLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

Exosomes as A Next-Generation Diagnostic and Therapeutic Tool in Prostate Cancer

Simita Gaglani et al.

Summary: Extracellular vesicles (EVs) play a crucial role in non-invasive liquid biopsy for cancer detection, with exosomes having significant diagnostic value in prostate cancer and potential therapeutic applications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Add to Collection

Review Oncology

PSMA: a game changer in the diagnosis and treatment of advanced prostate cancer

Meghana Parsi et al.

Summary: PSMA plays a crucial role in the treatment of advanced prostate cancer, serving both diagnostic and therapeutic purposes. PSMA scans detect metastatic lesions missed by conventional imaging modalities, while PSMA ligand therapy has been proven beneficial with minimal toxicity for patients with advanced prostate cancer.

MEDICAL ONCOLOGY (2021)

Add to Collection

Review Oncology

Emerging methods for prostate cancer imaging: evaluating cancer structure and metabolic alterations more clearly

Adam Retter et al.

Summary: Imaging plays a crucial role in cancer management, with new techniques like diffusion-weighted imaging and PET being developed to overcome the limitations of conventional methods. Machine learning shows promising potential in cancer diagnosis and treatment, alongside advancements in MRI and new PET tracers.

MOLECULAR ONCOLOGY (2021)

Add to Collection

Review Biochemistry & Molecular Biology

New Insights into Molecular Mechanism behind Anti-Cancer Activities of Lycopene

Boon-Peng Puah et al.

Summary: Lycopene is a compound commonly found in tomatoes, known for its health benefits against cardiovascular diseases and cancers. It shows anti-cancer activity by suppressing oncogenes and modulating immune cells to inhibit tumor growth. In addition, lycopene also suppresses cancer through resolving inflammation.

MOLECULES (2021)

Add to Collection

Article Urology & Nephrology

Prostate Cancer Predisposition

Yasin Bhanji et al.

UROLOGIC CLINICS OF NORTH AMERICA (2021)

Add to Collection

Article Urology & Nephrology

Germline Predisposition to Prostate Cancer in Diverse Populations

Kelly K. Bree et al.

UROLOGIC CLINICS OF NORTH AMERICA (2021)

Add to Collection

Article Oncology

High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity

Susanne G. Kidd et al.

Summary: In primary prostate cancer, high expression of SCHLAP1 serves as a robust prognostic biomarker for predicting biochemical recurrence and is associated with adverse clinicopathological characteristics. The heterogeneity of SCHLAP1 expression emphasizes the importance of analyzing multiple samples for determination of a patient's SCHLAP1 status.

NEOPLASIA (2021)

Add to Collection

Article Oncology

A Novel Urine Exosomal lncRNA Assay to Improve the Detection of Prostate Cancer at Initial Biopsy: A Retrospective Multicenter Diagnostic Feasibility Study

Yun Li et al.

Summary: This study developed and validated a novel noninvasive post-DRE urine-based lncRNA assay for the diagnosis of prostate cancer (PCa) and clinically significant PCa. The assay demonstrated good diagnostic power and clinical utility, improving early diagnosis of PCa and high-grade PCa.

CANCERS (2021)

Add to Collection

Review Oncology

Prostate Cancer Liquid Biopsy Biomarkers' Clinical Utility in Diagnosis and Prognosis

Milena Matuszczak et al.

Summary: In prostate cancer, overdiagnosis and overtreatment are common problems. New liquid biopsy biomarker tests have been developed to improve diagnosis, prognosis, and decision-making. The current gold standard for diagnosing prostate cancer relies on digital rectal examination and elevated prostate-specific antigen levels before biopsy.

CANCERS (2021)

Add to Collection

Article Medicine, General & Internal

Associations between LncRNA MALAT1 Polymorphisms and Lymph Node Metastasis in Prostate Cancer

Ju-Chuan Hu et al.

Summary: Evidence suggests that certain SNPs of MALAT1 are significantly associated with the susceptibility to advanced Gleason grade and nodal metastasis in prostate cancer, indicating an enhanced oncogenic potential in the presence of these SNPs.

DIAGNOSTICS (2021)

Add to Collection

Review Oncology

Epidemiology and Prevention of Prostate Cancer

Giorgio Gandaglia et al.

Summary: Prostate cancer (PCa) rates vary profoundly worldwide, with incidence and mortality rates being highest in Northern Europe and the Caribbean, respectively. South-Central Asia has the lowest epidemiological burden. Family history, race, and hereditary syndromes are well-established risk factors for PCa. Modifiable risk factors may impact the risk of developing PCa and that of dying from the disease itself, but little evidence exists for any clear indication for prevention other than early diagnosis to reduce PCa mortality.

EUROPEAN UROLOGY ONCOLOGY (2021)

Add to Collection

Review Oncology

A European Model for an Organised Risk-stratified Early Detection Programme for Prostate Cancer

Hendrik Van Poppel et al.

Summary: With the introduction of new technologies such as risk calculators and magnetic resonance imaging, the argument to stop prostate cancer screening based on overdiagnosis is less valid. The structured risk assessment using these technologies allows for adequate response to the urgent need for early detection of PCa.

EUROPEAN UROLOGY ONCOLOGY (2021)

Add to Collection

Review Biochemical Research Methods

The role of liquid biopsies in prostate cancer management

Chi-Ju Kim et al.

Summary: Liquid biopsy serves as a valuable tool in cancer diagnosis and treatment guidance, utilizing biomarkers such as CTCs, EVs, and ctDNA. Prostate cancer ranks as the second most common cancer in males globally, with management strategies focusing on biopsy and prevention of metastatic disease.

LAB ON A CHIP (2021)

Add to Collection

Review Urology & Nephrology

Recent Global Patterns in Prostate Cancer Incidence and Mortality Rates

MaryBeth B. Culp et al.

EUROPEAN UROLOGY (2020)

Add to Collection

Article Oncology

Prostate cancer screening in Portugal: prevalence and perception of potential benefits and adverse effects

Raquel Braga et al.

EUROPEAN JOURNAL OF CANCER PREVENTION (2020)

Add to Collection

Article Oncology

Review of Recent Advances in Understanding the Role of Vitamin D in Reducing Cancer Risk: Breast, Colorectal, Prostate, and Overall Cancer

William B. Grant

ANTICANCER RESEARCH (2020)

Add to Collection

Article Oncology

Tomato consumption and intake of lycopene as predictors of the incidence of prostate cancer: the Adventist Health Study-2

Gary E. Fraser et al.

CANCER CAUSES & CONTROL (2020)

Add to Collection

Review Oncology

Exosomal microRNAs as liquid biopsy biomarkers in prostate cancer

Jingpu Wang et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)

Add to Collection

Review Oncology

Combination radium-223 therapies in patients with bone metastases from castration-resistant prostate cancer: A review

M. C. Cursano et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Beneficial Properties of Green Tea Catechins

Claudia Musial et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Influence of Diet and Nutrition on Prostate Cancer

Makoto Matsushita et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Oncology

Comprehensive metabolomics analysis of prostate cancer tissue in relation to tumor aggressiveness and TMPRSS2-ERG fusion status

Ilona Dudka et al.

BMC CANCER (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Exosomes in Prostate Cancer Diagnosis, Prognosis and Therapy

Tomasz Lorenc et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Review Oncology

Role of Calcium Signaling in Prostate Cancer Progression: Effects on Cancer Hallmarks and Bone Metastatic Mechanisms

Juan A. Ardura et al.

CANCERS (2020)

Add to Collection

Article Oncology

Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

C. Parker et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Review Biochemistry & Molecular Biology

Hereditary Predisposition to Prostate Cancer: From Genetics to Clinical Implications

Andreia Brandao et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Add to Collection

Article Oncology

A Panel of Urinary Volatile Biomarkers for Differential Diagnosis of Prostate Cancer from Other Urological Cancers

Ana Rita Lima et al.

CANCERS (2020)

Add to Collection

Review Urology & Nephrology

A review of social determinants of prostate cancer risk, stage, and survival

Steven S. Coughlin

PROSTATE INTERNATIONAL (2020)

Add to Collection

Article Oncology

Effect of Smoking on Oncological Outcome among Prostate Cancer Patients after Radical Prostatectomy with Neoadjuvant Hormonal Therapy

Nobuaki Sato et al.

CANCER INVESTIGATION (2020)

Add to Collection

Review Pharmacology & Pharmacy

Altered expression of cytochrome P450 enzymes involved in metabolism of androgens and vitamin D in the prostate as a risk factor for prostate cancer

Oksana V. Maksymchuk et al.

PHARMACOLOGICAL REPORTS (2020)

Add to Collection

Article Endocrinology & Metabolism

Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume

Nativ Omri et al.

PROSTATE (2020)

Add to Collection

Review Nutrition & Dietetics

Dietary Factors and Supplements Influencing Prostate-Specific Antigen (PSA) Concentrations in Men with Prostate Cancer and Increased Cancer Risk: An Evidence Analysis Review Based on Randomized Controlled Trials

Maria G. Grammatikopoulou et al.

NUTRIENTS (2020)

Add to Collection

Article Multidisciplinary Sciences

The use of prostate specific antigen density to predict clinically significant prostate cancer

Igor Yusim et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Review Medical Laboratory Technology

Analysis of urinary VOCs using mass spectrometric methods to diagnose cancer: A review

Bruno Ruiz Brandao da Costa et al.

CLINICAL MASS SPECTROMETRY (2020)

Add to Collection

Article Urology & Nephrology

Mutational Profile of Aggressive, Localised Prostate Cancer from African Caribbean Men Versus European Ancestry Men

Laurie Tonon et al.

EUROPEAN UROLOGY (2019)

Add to Collection

Article Oncology

Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer

Qin Gao et al.

CLINICAL GENITOURINARY CANCER (2019)

Add to Collection

Review Oncology

The evolving role of diet in prostate cancer risk and progression

Adeel Kaiser et al.

CURRENT OPINION IN ONCOLOGY (2019)

Add to Collection

Meeting Abstract Oncology

Results of a 50 patient single-center phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer.

Michael Hofman et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Review Oncology

The Possibility of Preventive and Therapeutic Use of Green Tea Catechins in Prostate Cancer

Vladimir S. Rogovskii et al.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2019)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Prostate biopsy: when and how to perform

C. J. Das et al.

CLINICAL RADIOLOGY (2019)

Add to Collection

Meeting Abstract Oncology

RESIST-PC phase 2 trial: 177Lu-PSMA-617 radionuclide therapy for metastatic castrate-resistant prostate cancer.

Jeremie Calais et al.

JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Review Medicine, General & Internal

Obesity, Inflammation, and Prostate Cancer

Kazutoshi Fujita et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Breast Cancer Metabolomics: From Analytical Platforms to Multivariate Data Analysis. A Review

Catarina Silva et al.

METABOLITES (2019)

Add to Collection

Article Food Science & Technology

Comparative Analysis of Lycopene Content from Different Tomato-Based Food Products on the Cellular Activity of Prostate Cancer Cell Lines

Nathalia da Costa Pereira Soares et al.

FOODS (2019)

Add to Collection

Article Public, Environmental & Occupational Health

Smoking history, intensity, and duration and risk of prostate cancer recurrence among men with prostate cancer who received definitive treatment

Saira Khan et al.

ANNALS OF EPIDEMIOLOGY (2019)

Add to Collection

Article Oncology

Identification of a biomarker panel for improvement of prostate cancer diagnosis by volatile metabolic profiling of urine

Ana Rita Lima et al.

BRITISH JOURNAL OF CANCER (2019)

Add to Collection

Review Oncology

Long non-coding RNAs in prostate cancer: Functional roles and clinical implications

Yun-Hua Xu et al.

CANCER LETTERS (2019)

Add to Collection

Article Multidisciplinary Sciences

12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population

Ryo Takata et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Article Oncology

Investigating the effects of lycopene and green tea on the metabolome of men at risk of prostate cancer: The ProDiet randomised controlled trial

Rhona A. Beynon et al.

INTERNATIONAL JOURNAL OF CANCER (2019)

Add to Collection

Review Biochemistry & Molecular Biology

Anti-Cancer Effects of Green Tea Polyphenols Against Prostate Cancer

Yasuyoshi Miyata et al.

MOLECULES (2019)

Add to Collection

Review Oncology

Epidemiology of Prostate Cancer

Prashanth Rawla

WORLD JOURNAL OF ONCOLOGY (2019)

Add to Collection

Article Medicine, Research & Experimental

Prostate Cancer Disparities by Race and Ethnicity: From Nucleotide to Neighborhood

Timothy R. Rebbeck

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Add to Collection

Article Medicine, Research & Experimental

Long noncoding RNA BDNF-AS is associated with clinical outcomes and has functional role in human prostate cancer

Wensheng Li et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Add to Collection

Review Public, Environmental & Occupational Health

Social determinants of prostate cancer in the Caribbean: a systematic review and meta-analysis

Catherine R. Brown et al.

BMC PUBLIC HEALTH (2018)

Add to Collection

Review Oncology

Tobacco smoking and survival after a prostate cancer diagnosis: A systematic review and meta-analysis

Ellie Darcey et al.

CANCER TREATMENT REVIEWS (2018)

Add to Collection

Review Medicine, General & Internal

Screening for Prostate Cancer US Preventive Services Task Force Recommendation Statement

David C. Grossman et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Add to Collection

Article Oncology

[177Lu]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

Michael S. Hofman et al.

LANCET ONCOLOGY (2018)

Add to Collection

Article Urology & Nephrology

Do dietary calcium and vitamin D matter in men with prostate cancer?

Thierry Capiod et al.

NATURE REVIEWS UROLOGY (2018)

Add to Collection

Review Urology & Nephrology

Prostate cancer and social media

Stacy Loeb et al.

NATURE REVIEWS UROLOGY (2018)

Add to Collection

Review Oncology

Development and Application of Liquid Biopsies in Metastatic Prostate Cancer

Gareth J. Morrison et al.

CURRENT ONCOLOGY REPORTS (2018)

Add to Collection

Review Nutrition & Dietetics

Soy Consumption and the Risk of Prostate Cancer: An Updated Systematic Review and Meta-Analysis

Catherine C. Applegate et al.

NUTRIENTS (2018)

Add to Collection

Article Medicine, Research & Experimental

The Epidemiology of Prostate Cancer

Claire H. Pernar et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)

Add to Collection

Review Oncology

Association of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy A Systematic Review and Meta-analysis

Beat Foerster et al.

JAMA ONCOLOGY (2018)

Add to Collection

Review Oncology

Innovative Diagnostic Methods for Early Prostate Cancer Detection through Urine Analysis: A Review

Carmen Bax et al.

CANCERS (2018)

Add to Collection

Article Endocrinology & Metabolism

Overexpression of AR-regulated lncRNA TMPO-AS1 correlates with tumor progression and poor prognosis in prostate cancer

Wenhua Huang et al.

PROSTATE (2018)

Add to Collection

Editorial Material Medicine, General & Internal

Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline

Kari A. O. Tikkinen et al.

BMJ-BRITISH MEDICAL JOURNAL (2018)

Add to Collection

Review Pharmacology & Pharmacy

Cruciferous Vegetables as Antioxidative, Chemopreventive and Antineoplasic Functional Foods: Preclinical and Clinical Evidences of Sulforaphane Against Prostate Cancers

Paulo M. P. Ferreira et al.

CURRENT PHARMACEUTICAL DESIGN (2018)

Add to Collection

Review Public, Environmental & Occupational Health

Global Trends and Prostate Cancer: A Review of Incidence, Detection, and Mortality as Influenced by Race, Ethnicity, and Geographic Location

Harold Evelyn Taitt

AMERICAN JOURNAL OF MENS HEALTH (2018)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients

Kambiz Rahbar et al.

JOURNAL OF NUCLEAR MEDICINE (2017)

Add to Collection

Article Oncology

Low serum total testosterone level as a predictor of upstaging and upgrading in low-risk prostate cancer patients meeting the inclusion criteria for active surveillance

Matteo Ferro et al.

ONCOTARGET (2017)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

The 68Ga/177Lu theragnostic concept in PSMA targeting of castration-resistant prostate cancer: correlation of SUVmax values and absorbed dose estimates

Lorenza Scarpa et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

Add to Collection

Review Urology & Nephrology

Obesity and Prostate Cancer: A Focused Update on Active Surveillance, Race, and Molecular Subtyping

Adriana C. Vidal et al.

EUROPEAN UROLOGY (2017)

Add to Collection

Editorial Material Urology & Nephrology

Re: Family History and Probability of Prostate Cancer, Differentiated by Risk Category - A Nationwide Population-based Study

Eugenio Ventimiglia et al.

EUROPEAN UROLOGY (2017)

Add to Collection

Review Medicine, General & Internal

The Diagnosis and Treatment of Prostate Cancer A Review

Mark S. Litwin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)

Add to Collection

Article Endocrinology & Metabolism

Upregulation of the long non-coding RNA FALEC promotes proliferation and migration of prostate cancer cell lines and predicts prognosis of PCa patients

Ruizhe Zhao et al.

PROSTATE (2017)

Add to Collection

Review Oncology

Biomarkers in prostate cancer - Current clinical utility and future perspectives

Alexander Kretschmer et al.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)

Add to Collection

Article Chemistry, Medicinal

Assessment of Bone Metastases in Patients with Prostate Cancer-A Comparison between 99mTc-Bone-Scintigraphy and [68Ga]Ga-PSMA PET/CT

Lena Thomas et al.

PHARMACEUTICALS (2017)

Add to Collection

Review Urology & Nephrology

Obesity and prostate cancer

Marco Bandini et al.

CURRENT OPINION IN UROLOGY (2017)

Add to Collection

Article Oncology

Diet, body size, physical activity and risk of prostate cancer: An umbrella review of the evidence

Georgios Markozannes et al.

EUROPEAN JOURNAL OF CANCER (2016)

Add to Collection

Article Radiology, Nuclear Medicine & Medical Imaging

The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer

Ali Afshar-Oromieh et al.

JOURNAL OF NUCLEAR MEDICINE (2016)

Add to Collection

Article Urology & Nephrology

Diagnostic Efficacy of 68Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

Tobias Maurer et al.

JOURNAL OF UROLOGY (2016)

Add to Collection

Review Chemistry, Analytical

Application and Uses of Electronic Noses for Clinical Diagnosis on Urine Samples: A Review

Laura Capelli et al.

SENSORS (2016)

Add to Collection

Review Oncology

Biomarker Discovery in Human Prostate Cancer: an Update in Metabolomics Studies

Ana Rita Lima et al.

TRANSLATIONAL ONCOLOGY (2016)

Add to Collection

Article Oncology

A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy

James McKiernan et al.

JAMA ONCOLOGY (2016)

Add to Collection

Article Chemistry, Analytical

Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study

Wiktoria Struck-Lewicka et al.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2015)

Add to Collection

Editorial Material Urology & Nephrology

PROSTATE CANCER Intrapatient heterogeneity in prostate cancer

Himisha Beltran et al.

NATURE REVIEWS UROLOGY (2015)

Add to Collection

Article Urology & Nephrology

Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance

Ottavio de Cobelli et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)

Add to Collection

Review Oncology

Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis

K. S. Louie et al.

ANNALS OF ONCOLOGY (2015)

Add to Collection

Article Multidisciplinary Sciences

Urinary Volatile Organic Compounds for the Detection of Prostate Cancer

Tanzeela Khalid et al.

PLOS ONE (2015)

Add to Collection

Review Oncology

Epidemiology, Etiology, Diagnosis and Treatment of Prostate Cancer

Muhammad Daniyal et al.

ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (2014)

Add to Collection

Review Oncology

Dietary factors and risk for advanced prostate cancer

Wambui G. Gathirua-Mwangi et al.

EUROPEAN JOURNAL OF CANCER PREVENTION (2014)

Add to Collection

Review Biotechnology & Applied Microbiology

Novel Tools for Prostate Cancer Prognosis, Diagnosis, and Follow-Up

Andreas Dimakakos et al.

BIOMED RESEARCH INTERNATIONAL (2014)

Add to Collection

Review Radiology, Nuclear Medicine & Medical Imaging

Metabolomic imaging of prostate cancer with magnetic resonance spectroscopy and mass spectrometry

Eva-Margarete Spur et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)

Add to Collection

Review Biochemistry & Molecular Biology

The Present and Future of Prostate Cancer Urine Biomarkers

Marina Rigau et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Add to Collection

Article Medicine, General & Internal

Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer

C. Parker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2013)

Add to Collection

Article Endocrinology & Metabolism

Metabolomic signatures of aggressive prostate cancer

Jonathan E. McDunn et al.

PROSTATE (2013)

Add to Collection

Review Oncology

Defining prostate cancer risk before prostate biopsy

Raj P. Pal et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2013)

Add to Collection

Article Oncology

Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up

Gerald L. Andriole et al.

JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)

Add to Collection

Article Oncology

Ethnic differences in prostate cancer

P. Kheirandish et al.

BRITISH JOURNAL OF CANCER (2011)

Add to Collection

Article Oncology

Global prostate cancer incidence and the migration, settlement, and admixture history of the Northern Europeans

Kristin Gunderson et al.

CANCER EPIDEMIOLOGY (2011)

Add to Collection

Article Endocrinology & Metabolism

Chromosome 8q24 Variants Are Associated With Prostate Cancer Risk in a High Risk Population of African Ancestry

Michael N. Okobia et al.

PROSTATE (2011)

Add to Collection

Article Genetics & Heredity

Characterizing Genetic Risk at Known Prostate Cancer Susceptibility Loci in African Americans

Christopher A. Haiman et al.

PLOS GENETICS (2011)

Add to Collection

Article Public, Environmental & Occupational Health

Smoking as a Risk Factor for Prostate Cancer: A Meta-Analysis of 24 Prospective Cohort Studies

Michael Huncharek et al.

AMERICAN JOURNAL OF PUBLIC HEALTH (2010)

Add to Collection

Editorial Material Oncology

Obesity, Endogenous Hormone Metabolism, and Prostate Cancer Risk: A Conundrum of Highs and Lows

Rudolf Kaaks et al.

CANCER PREVENTION RESEARCH (2010)

Add to Collection

Review Oncology

Metastasis and bone loss: Advancing treatment and prevention

Robert E. Coleman et al.

CANCER TREATMENT REVIEWS (2010)

Add to Collection

Article Public, Environmental & Occupational Health

Meat and Meat-related Compounds and Risk of Prostate Cancer in a Large Prospective Cohort Study in the United States

Rashmi Sinha et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)

Add to Collection

Article Oncology

Lycopene inhibits IGF-I signal transduction and growth in normal prostate epithelial cells by decreasing DHT-modulated IGF-I production in co-cultured reactive stromal cells

Xunxian Liu et al.

CARCINOGENESIS (2008)

Add to Collection

Article Medicine, General & Internal

Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer

Lionel L. Banez et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Add to Collection

Article Medicine, Research & Experimental

Modulation of prostate cancer genetic risk by ornega-3 and ornega-6 fatty acids

Isabelle M. Berquin et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Add to Collection

Article Oncology

Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24

Miia Suuriniemi et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)

Add to Collection

Article Urology & Nephrology

Smoking and risk of fatal prostate cancer in a prospective US study

Sabine Rohrmann et al.

UROLOGY (2007)

Add to Collection

Article Multidisciplinary Sciences

Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men

Matthew L. Freedman et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Add to Collection

© Peeref 2019-2024. All rights reserved.